Combination of trastuzumab, oxaliplatin, and docetaxel as first-line treatment in HER2-positive metastatic breast cancer patients: First-step results of a phase II trial (HOT trial) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results